Prognostic factors in advanced colorectal carcinoma
- 1 May 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 74 (5) , 786-794
- https://doi.org/10.1016/0002-9343(83)91066-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Metastatic colorectal carcinoma: A prospective randomized trial of Methyl-CCNU, 5-fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-strep)Cancer, 1983
- Lactic dehydrogenase in the monitoring and prognosis of testicular cancerCancer, 1981
- Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group reportCancer, 1980
- Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-strep)Cancer, 1980
- Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomasBlood, 1979
- A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinomaCancer, 1979
- A computer program for linear logistic regression analysisComputer Programs in Biomedicine, 1974
- Carcinoembryonic antigen (CEA) assayA laboratory adjunct in the diagnosis and management of cancerHuman Pathology, 1974
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataPublished by JSTOR ,1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958